Research suggests that some cannabinoids may, in fact, increase focus, suppress appetite and keep users awake.
One thing that appears to have gone unnoticed in all of the front page articles is the fact that Canada is not the largest jurisdiction in the world in which recreational (adult use) marijuana is lawful.
To say that all CBD is unlawful because it is a derivative of Cannabis is nonsensical; there are lawful and unlawful types of Cannabis.
The “Regulatory Status of Cannabidiol in the United States: A Perspective”, an article I co-wrote with Dr. Jamie Corroon, was published this week in Cannabis and Cannabinoid Research, a peer reviewed journal.
Congress has not yet enacted the 2018 Farm Bill. It is likely to pass within the next 8 weeks or so. However, what is the current legal status of industrial hemp now that the 2014 Farm Act has expired?
The DEA has rescheduled Epidiolex, a product containing CBD derived from marijuana, from schedule 1 to schedule 5.
We can expect a bumpy ride until the 2018 Farm Bill is passed. So, buckle in and hold on for the next few months. Change is coming.
The Ohio Board of Pharmacy issued two Guidance Documents regarding CBD this week that have caused an uproar. Is the Pharmacy Board right?
I am not exaggerating when I say that the future of your cannabis business, and the industry at large, may depend on the outcome of this case.
The next big battleground for CBD is the extent to which it will be regulated by the FDA.